Cargando…
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
Cytokines, many of which signal through the JAK–STAT (Janus kinase–Signal Transducers and Activators of Transcription) pathway, play a central role in the pathogenesis of inflammatory and autoimmune diseases. Currently three JAK inhibitors have been approved for clinical use in USA and/or Europe: to...
Autores principales: | T. Virtanen, Anniina, Haikarainen, Teemu, Raivola, Juuli, Silvennoinen, Olli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373396/ https://www.ncbi.nlm.nih.gov/pubmed/30701418 http://dx.doi.org/10.1007/s40259-019-00333-w |
Ejemplares similares
-
Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
por: Raivola, Juuli, et al.
Publicado: (2019) -
Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021) -
Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain
por: Raivola, Juuli, et al.
Publicado: (2018) -
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain
por: Virtanen, Anniina T., et al.
Publicado: (2023) -
Nucleotide-binding mechanisms in pseudokinases
por: Hammarén, Henrik M., et al.
Publicado: (2016)